Cue Biopharma, Inc. reports

Company location: Boston, MA
Fiscal year end: 31 December

Cue Biopharma, Inc. has filed 523 SEC EDGAR filings since 19 Jun 2015

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 151-175 of 523 matching filings.

Per page

25

Current page

7

10-K File 001-38327

10-K

Filing date: 28 Mar 2024
Reporting date: 31 Dec 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G File 005-90232

CUEBIOPHARMA13G

Filing date: 11 Mar 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 08 Mar 2024
Reporting date: 06 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 08 Mar 2024
Reporting date: 06 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 08 Mar 2024
Reporting date: 06 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 08 Mar 2024
Reporting date: 06 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 08 Mar 2024
Reporting date: 06 Mar 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 22 Feb 2024
Reporting date: 20 Feb 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-90232

SC 13G filing

Filing date: 07 Feb 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-90232

SC 13G filing

Filing date: 31 Jan 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 04 Jan 2024
Reporting date: 02 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 04 Jan 2024
Reporting date: 02 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 04 Jan 2024
Reporting date: 02 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 04 Jan 2024
Reporting date: 02 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4

Filing date: 04 Jan 2024
Reporting date: 02 Jan 2024
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38327

10-Q

Filing date: 03 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-38327

8-K

Filing date: 14 Sep 2023
Reporting date: 12 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 29 Aug 2023
Reporting date: 25 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 16 Aug 2023
Reporting date: 14 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-38327

10-Q

Filing date: 08 Aug 2023
Reporting date: 30 Jun 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jul 2023
Reporting date: 21 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jul 2023
Reporting date: 21 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jul 2023
Reporting date: 21 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jul 2023
Reporting date: 21 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 25 Jul 2023
Reporting date: 21 Jul 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .